Physician profile
Allan H Bailey
NPI 1396739140
$4,680.37
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,233 · 2020: $1,315 · 2021: $2,049 · 2022: $29.67 · 2023: $37.46 · 2024: $15.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,555.76 | 2019-2023 | Skyrizi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $897.09 | 2019-2023 | Xifaxan |
| Janssen Biotech, INC. | $515.36 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $474.24 | 2019-2024 | Entyvio |
| Romark Laboratories, Lc | $268.68 | 2019-2020 | |
| Qol Medical, LLC | $213.45 | 2019-2021 | |
| Gilead Sciences, INC. | $162.49 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $117.26 | 2019-2021 | |
| Redhill Biopharma INC. | $108.06 | 2020-2021 | |
| Daiichi Sankyo INC. | $85.09 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $56.07 | 2020-2021 | |
| Shire North American Group INC | $51.26 | 2019 | |
| Intercept Pharmaceuticals, INC. | $46.77 | 2021 | |
| Ironwood Pharmaceuticals, INC | $45.85 | 2020-2021 | |
| Biocompatibles, INC. | $19.32 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17.52 | 2019 | |
| Alfasigma USA, INC. | $16.87 | 2021 | |
| Shionogi INC | $15.96 | 2019 | |
| Axonics, INC. | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.